Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre J Dilda

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Molecular Aspects of Medicine|December 10, 2009
Mitochondria as targets in angiogenesis inhibitionDanielle Park, Pierre J Dilda
Frontiers in Pharmacology|August 27, 2014
Glutathione S-conjugates as prodrugs to target drug-resistant tumorsEmma E Ramsay, Pierre J Dilda
Discovery Medicine|August 14, 2010
Selective targeting of mitochondria for the treatment of cancerPierre J Dilda, Philip J Hogg
Cancer Treatment Reviews|July 13, 2007
Arsenical-based cancer drugsPierre J Dilda, Philip J Hogg
Pharmaceutical Research|September 16, 2011
Mitochondrial metabolism inhibitors for cancer therapyEmma E Ramsay, Philip J Hogg, Pierre J Dilda
Cancer Research|December 17, 2005
Para to ortho repositioning of the arsenical moiety of the angiogenesis inhibitor 4-(N-(S-glutathionylacetyl)amino)phenylarsenoxide results in a markedly increased cellular accumulation and antiproliferative activityPierre J Dilda, Stephanie Decollogne, Michael Rossiter-Thornton, et al.
Drug Discovery Today|February 20, 2021
Developing new drugs that activate the protective arm of the renin-angiotensin system as a potential treatment for respiratory failure in COVID-19 patientsMathilde Latil, Serge Camelo, Stanislas Veillet, et al.
Oxidative Medicine and Cellular Longevity|February 1, 2021
Beyond AREDS Formulations, What Is Next for Intermediate Age-Related Macular Degeneration (iAMD) Treatment? Potential Benefits of Antioxidant and Anti-inflammatory Apocarotenoids as NeuroprotectorsSerge Camelo, Mathilde Latil, Stanislas Veillet, et al.
Cancer Biology & Therapy|December 9, 2014
Targeting of two aspects of metabolism in breast cancer treatmentBevan P Gang, Pierre J Dilda, Phillip J Hogg, et al.
Molecular Cancer Therapeutics|June 12, 2015
Sensitization of Glioblastoma Cells to Irradiation by Modulating the Glucose MetabolismHan Shen, Eric Hau, Swapna Joshi, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Molecular Aspects of Medicine|December 10, 2009
Mitochondria as targets in angiogenesis inhibitionDanielle Park, Pierre J Dilda
Frontiers in Pharmacology|August 27, 2014
Glutathione S-conjugates as prodrugs to target drug-resistant tumorsEmma E Ramsay, Pierre J Dilda
Discovery Medicine|August 14, 2010
Selective targeting of mitochondria for the treatment of cancerPierre J Dilda, Philip J Hogg
Cancer Treatment Reviews|July 13, 2007
Arsenical-based cancer drugsPierre J Dilda, Philip J Hogg
Pharmaceutical Research|September 16, 2011
Mitochondrial metabolism inhibitors for cancer therapyEmma E Ramsay, Philip J Hogg, Pierre J Dilda
Cancer Research|December 17, 2005
Para to ortho repositioning of the arsenical moiety of the angiogenesis inhibitor 4-(N-(S-glutathionylacetyl)amino)phenylarsenoxide results in a markedly increased cellular accumulation and antiproliferative activityPierre J Dilda, Stephanie Decollogne, Michael Rossiter-Thornton, et al.
Drug Discovery Today|February 20, 2021
Developing new drugs that activate the protective arm of the renin-angiotensin system as a potential treatment for respiratory failure in COVID-19 patientsMathilde Latil, Serge Camelo, Stanislas Veillet, et al.
Oxidative Medicine and Cellular Longevity|February 1, 2021
Beyond AREDS Formulations, What Is Next for Intermediate Age-Related Macular Degeneration (iAMD) Treatment? Potential Benefits of Antioxidant and Anti-inflammatory Apocarotenoids as NeuroprotectorsSerge Camelo, Mathilde Latil, Stanislas Veillet, et al.
Cancer Biology & Therapy|December 9, 2014
Targeting of two aspects of metabolism in breast cancer treatmentBevan P Gang, Pierre J Dilda, Phillip J Hogg, et al.
Molecular Cancer Therapeutics|June 12, 2015
Sensitization of Glioblastoma Cells to Irradiation by Modulating the Glucose MetabolismHan Shen, Eric Hau, Swapna Joshi, et al.
Pageof 4